Compare

Propanc Biopharma, Inc. vs PMGC Holdings Inc. vs Imunon, Inc. vs CalciMedica, Inc.

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal yearPropanc Biopharma, Inc.
PPCB
PMGC Holdings Inc.
ELAB
Imunon, Inc.
IMNN
CalciMedica, Inc.
CALC
Year ended2026-06-302025-12-312025-12-312025-12-31
Revenuen/a$590.1Kn/an/a
Revenue growth (YoY)n/an/an/an/a
Gross marginn/a31.4%n/an/a
Operating marginn/an/an/an/a
Net marginn/an/mn/an/a
Net income-$18.86M-$7.75M-$14.50M-$29.56M
EPS (Diluted)-$17.62n/a-$6.83-$1.97
Operating cash flow-$5.68M-$5.93M-$13.90M-$21.18M
Free cash flow-$5.69M-$6.38M-$14.18M-$21.21M
Cash & equivalentsn/an/a$8.78M$11.52M
Total assets$12.78M$12.87M$12.29M$13.59M
Total liabilities$3.38M$5.03M$5.23M$20.23M
Shareholders' equity$9.40M$7.84M$7.06M-$6.64M
Return on year-end equity-200.6%-98.9%-205.3%n/a
Shares outstanding3.31M80.7K3.42M15.44M

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal yearPropanc Biopharma, Inc.PMGC Holdings Inc.Imunon, Inc.CalciMedica, Inc.
Latestn/a$590.1K
Ended 2025-12-31
$500.0K
Ended 2022-12-31
n/a
1 year earliern/an/a$500.0K
Ended 2021-12-31
n/a
2 years earliern/a$1.71M
Ended 2023-12-31
$500.0K
Ended 2020-12-31
n/a
3 years earliern/a$766.3K
Ended 2022-12-31
$500.0K
Ended 2019-12-31
n/a
4 years earliern/an/a$500.0K
Ended 2018-12-31
n/a